• About Background Image | Premier Shockwave

Ossatron for Elbow Pain

The Non-Invasive Surgical Alternative for Elbow Pain

The OssaTron is a high-energy shockwave device that provides a non-invasive surgical alternative for patients diagnosed with chronic lateral epicondylitis. This noninvasive out-patient procedure represents a breakthrough treatment for this condition.

Using a unique technology known as Orthotripsy, the OssaTron device emits a series of high-energy acoustic impulses (shockwaves) to stimulate healing of the affected elbow.

Is It Safe?

Yes. Developed in 1991 and widely used in Europe, the OssaTron is the first shockwave device specifically designed and FDA approved for orthopaedic use. A wealth of medical experience and state-of-the art engineering have been built into the OssaTron. Extensive clinical studies and tests have confirmed its safety and efficacy.

What are the Expected Results?

Orthotripsy with the OssaTron has been proven to be effective over 91% of the time with only one treatment.1 Pain relief typically begins within four weeks of the procedure, and continues up through six months.

What are the Possible Side Effects or Complications?

Orthotripsy has minimal risks. In some cases it may cause skin reddening, bruising, temporary numbness or tingling. In rare instances it may cause the lateral epicondyle to tear.

Why Consider Orthotripsy Versus Surgery?

Orthotripsy with the OssaTron device has a proven success rate that exceeds that of open surgery. Orthotripsy requires a minimal amount of time and patients can go home the same day the procedure is performed.

Most importantly, patients can continue to use their arm and return to normal activity within days of the procedure.

What if I Have a Special Health Condition?

The safety and effectiveness of the OssaTron procedure has not yet been determined on people with the following health conditions. Your doctor will provide you with information about how these and other health conditions might affect the determination to perform the Orthotripsy procedure:

  • Tarsal tunnel syndrome, or other nerve entrapment disorders
  • Diabetic neuropathy
  • Significant peripheral vascular disease
  • Severe osteoarthritis
  • Rheumatoid arthritis
  • Osteoporosis
  • Metabolic disorders
  • Malignancies
  • Paget’s disease
  • Osteomyelitis
  • Systemic infection
  • Anyone who is taking medication for bleeding problems, or has a history of bleeding or blood clotting problems should consult their doctor
  • This procedure is not recommended for pregnant women
  • This procedure is not recommended for children 

What Will Happen to You the Day of the Procedure?

You will be asked to arrive at the hospital or surgery center a few hours before your scheduled procedure. The staff may also need you to complete paperwork if you have not already done so.

Prior to administering anesthesia, the physician will palpate the elbow to determine the area of maximum tenderness (the target area) and mark the area with a surgical marking pen.

The procedure can cause discomfort or pain, so anesthesia is commonly given before the procedure.

You will stay at the hospital or surgery center for a short recovery period. You will receive post-operative instructions from your physician to follow during your recovery.

Will my Insurance Pay for the Procedure?

Many health insurance companies are incorporating high-energy Orthotripsy procedures (CPT Code 0102T) into their medical policies. It is recommended that you ask your insurance provider if the procedure is a covered benefit.

Your doctor and the treating facility will make every effort to obtain an approval from your insurance company. However, your insurance company has the final authority to approve or deny coverage. Patients are the strongest advocates in obtaining approval for insurance benefits. If you are denied coverage, you have the right to appeal that coverage decision to your insurance company's Medical Director.

  1. Shock Wave Therapy for Patients with Lateral Epicondylitis of the Elbow: A One to Two Year Follow-up Study, TheAmerican Journal of Sports Medicine, Vol. 30, No. 3, 2002. C. Wang, M.D.